18899-1-AP

antibody from Proteintech Group

Targeting: CEP170 FAM68A, KAB, KIAA0470

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

18899-1-AP

Provider

Proteintech Group

Product name

CEP170/CEP170L antibody

Antibody type

Polyclonal

Description

KD/KO validated CEP170/CEP170L antibody (Cat. #18899-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, WB, ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

LUC7L3 is a downstream factor of SRSF1 and prevents genomic instability.

Zhang X, Guo J, Shi X, Zhou X, Chen Q
Cell insight 2024 Jun;3(3):100170

---

NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma.

Wei R, Cui X, Min J, Lin Z, Zhou Y, Guo M, An X, Liu H, Janz S, Gu C, Wang H, Yang Y
Acta pharmaceutica Sinica. B 2022 Aug;12(8):3313-3325

---

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability.

Tang X, Guo M, Ding P, Deng Z, Ke M, Yuan Y, Zhou Y, Lin Z, Li M, Gu C, Gu X, Yang Y
Signal transduction and targeted therapy 2021 Oct 7;6(1):361

---

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma.

Gu C, Wang W, Tang X, Xu T, Zhang Y, Guo M, Wei R, Wang Y, Jurczyszyn A, Janz S, Beksac M, Zhan F, Seckinger A, Hose D, Pan J, Yang Y
Molecular cancer 2021 Jun 5;20(1):84